Postoprative analgesia effect by oxycodone hydrochlorid in laryngectomy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-16007903

Enrollment

Unknown

Registered

2016-02-05

Start date

2016-02-06

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post operative pain

Interventions

oxycodone group:patient-controlled intravenous analgesia with oxycodone hydrochlorid

morphine group:patient-controlled intravenous analgesia with morphine hydrochlorid

Eligibility

Sex/Gender

All

Age

20 Years to 69 Years

Inclusion criteria

Inclusion criteria: Patients with full ability to communicate undergoing selective laryngectomy, ASA status I-II, aged 20-69 years old, no restriction on gender

Exclusion criteria

Exclusion criteria: 1. Patients allergic to oxycodone hydrochlorid or any drugs used during this study; 2. patients on long-term therapy with narcosis analgeticsedative or non-steroid anti-inflammatory drugs; 3. patients with neuromuscular disorders; 4. patients with allergic disorders; 5. other situations unsuitable for this study

Design outcomes

Primary

Measure	Time frame
drug consumption;drug recruitment;total bolus;VAS scores;	—

Secondary

Measure	Time frame
Ramsay scores;SBP,DBP,MAP,HR,SpO2;cough scores;Nausea scores;vomiting scores;	—

Countries

China

Contacts

Public ContactWenxian Li

wenxianli66@gmail.com+86 13917426838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026